by Jordana Choucair | Oct 25, 2021 | Providers
Billionaire investor Mark Cuban and the Purchaser Business Group on Health (PBGH) are each launching new pharmacy benefit managers (PBMs) amid criticism that PBMs aren’t transparent about how much they save consumers. Cuban’s company will include...
by Jordana Choucair | Oct 25, 2021 | Payers
CMS released new guidance requiring state Medicaid programs and the Children’s Health Insurance Program to cover treatments for COVID-19 without cost sharing. The coverage requirement includes drugs approved by the FDA for treating COVID-19, preventive therapies,...
by Jordana Choucair | Oct 25, 2021 | Life Sciences
Anthony Fauci told ABC News that if regulators authorize COVID-19 vaccines for children between the ages of 5 and 11, shorts could be available within the first two weeks of November. A key FDA advisory committee plans to meet Tuesday to discuss shots for that age...
by Jordana Choucair | Oct 25, 2021 | D.C. News
Congressional Democrats are considering scaling back their prescription drug pricing plan by exempting new, expensive drugs from Medicare price negotiation. The change would be a major shift away from earlier proposals that focused mostly on drugs that don’t face any...
by Jordana Choucair | Oct 22, 2021 | D.C. News
President Joe Biden said during a CNN town hall that the inclusion of expanded dental, hearing, and vision benefits through Medicare in Democrats’ social spending plan is a “reach.” The president said there have been related discussions about...
by Jordana Choucair | Oct 22, 2021 | Life Sciences
A panel of CDC vaccine advisors approved boosters for Moderna and Johnson & Johnson COVID-19 vaccines, as well as mixing-and-matching shots. The panel unanimously voted 15-0 to recommend booster doses for all individuals who received the Johnson & Johnson...
Recent Comments